succinic semialdehyde dehydrogenase deficiency


Also found in: Wikipedia.

succinic semialdehyde dehydrogenase deficiency

A rare (±350 families in the world literature) autosomal recessive condition (OMIM:271980) characterised by a defect in metabolism of the neurotransmitter 4-aminobutyric acid (GABA), resulting in an accumulation of GHB, a compound with numerous neuromodulatory properties.

Clinical findings
Most common in consanguineous pedigrees; delays in intellectual, motor, speech and language milestones; ocular problems, including strabismus, nystagmus, retinitis and oculomotor apraxia; also, hypotonia, hyporreflexia, seizures, nonprogressive ataxia, hyperkinesis, hyperreflexia, autism, myopathy and choreoathetosis.

Imaging
T2-weighted signal defects of the globus pallidus (bilaterally and symmetrically), brainstem and cerebellar dentate nucleus; presence of subcortical white matter, attributed to oedema or an inflammation.

Molecular pathology
Mutation of ALDH5A1 on chromosome 6p22.
References in periodicals archive ?
Mary Jane's son, Bart (29), has succinic semialdehyde dehydrogenase deficiency and lives in his own apartment supported by 24-hour caregivers.
The diseases identified to date include: tyrosine hydroxylase deficiency (TH deficiency); aromatic L-amino acid decarboxylase deficiency (ALADD or AADC); GTP-1 cyclohydrolase deficiency (dopa-responsive dystonia); dihydropteridine reductase deficiency (DHPR); and succinic semialdehyde dehydrogenase deficiency (SSADH).